New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GSK;NVS;CBST;TEVA;JAZZ;BP;CHK From The Last 14 Days
Check below for free stories on GSK;NVS;CBST;TEVA;JAZZ;BP;CHK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
September 30, 2014
07:30 EDTNVS, GSKSachs Associates to hold a conference
14th Annual Biotech in Europe Forum for Global Partnering and Investment to be held in Basel, Switzerland on September 30-October 1.
September 29, 2014
13:47 EDTGSKGlaxoSmithKline reports 45% survival rate of Tafinlar-treated melanoma patients
Subscribe for More Information
08:07 EDTNVSPhase 2 trial of binimetinib in NRAS melanoma shows promising clinical activity
Subscribe for More Information
07:26 EDTGSKInforma Business Information to hold a conference
Subscribe for More Information
07:19 EDTTEVAUBS to hold a field trip
Subscribe for More Information
06:28 EDTBPRoyal Dutch Shell, BP in running for Abu Dhabi oil deal, The Telegraph says
Royal Dutch Shell (RDS.A) and BP (BP) are in the final running for a deal to operate oil fields in Abu Dhabi's onshore fields. , reports The Telegraph. Suhail Al-Mazrouei, minister of energy for the United Arab Emirates and a member of the Gulf state’s powerful Supreme Petroleum Council, said both companies remained under consideration, adding that "they have been legacy partners, and we hope they will have a chance and play a role in the future of the oil industry in Abu Dhabi.” Reference Link
05:26 EDTTEVAProtalix appoints Moshe Manor as CEO
Subscribe for More Information
September 26, 2014
07:30 EDTNVSNovartis drug Signifor LAR recommended by CHMP for EU approval
The Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, adopted a positive opinion for Signifor long acting release, or LAR, formulation to treat adult patients with acromegaly for whom surgery is not an option or has not been curative and who are inadequately controlled on treatment with a first-generation somatostatin analogue, or SSA. If approved in the EU, this next-generation SSA could fill a current unmet need, providing a new therapeutic option for the approximately 45% of acromegaly patients whose growth hormone, or GH, or insulin-like growth factor-1, or IGF-1, levels remain inadequately controlled despite treatment with currently available SSAs.
September 25, 2014
11:12 EDTBPBP volatility increases, shares at nine-month low
Subscribe for More Information
09:36 EDTBPActive equity options trading on open
Subscribe for More Information
07:54 EDTJAZZJazz Pharmaceuticals management to meet with UBS
Subscribe for More Information
06:11 EDTBPStocks with implied volatility below IV index mean; BP HD
Subscribe for More Information
05:36 EDTGSKGlaxoSmithKline names Philip Hampton Non-Executive Director
Subscribe for More Information
05:28 EDTNVSNovartis AIN457 meets primary endpoint in two Phase III studies
Subscribe for More Information
September 24, 2014
13:15 EDTBPJudge says BP can't seek restitution of 2010 Gulf oil spill claims, AP says
Subscribe for More Information
12:49 EDTBPJudge says BP can't seek restitution of spill claims, Bloomberg reports
10:18 EDTGSKGlaxoSmithKline set to name RBS' Philip Hampton as next chairman, Sky News says
Subscribe for More Information
07:55 EDTJAZZJazz Pharmaceuticals management to meet with UBS
Meetings to be held in Geneva/Zurich on September 24 hosted by UBS.
September 23, 2014
08:29 EDTGSKGlaxoSmithKline weakness creates buying opportunity, says Argus
Subscribe for More Information
08:07 EDTGSKFDA Pediatric Advisory Committee to hold a meeting
Subscribe for More Information
September 22, 2014
16:07 EDTNVSAnacor announces commercial launch of KERYDIN topical solution in U.S.
Subscribe for More Information
16:00 EDTBPOptions Update; September 22, 2014
iPath S&P 500 VIX Short-Term Futures up 91c to 28.14. Option volume leaders: AAPL TSLA NFLX C TWTR AMZN BP PBR CLF WLT according to Track Data.
10:15 EDTGSKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:21 EDTGSKEBD Group to hold a conference
Subscribe for More Information
05:27 EDTGSKGlaxoSmithKline upgraded to Buy from Neutral at Goldman
Subscribe for More Information
September 20, 2014
20:43 EDTCHKChesapeake, Weatherford seem attractive, Barron's says
Subscribe for More Information
September 19, 2014
05:58 EDTGSKGlaxoSmithKline to pay GBP 297M fine to Chinese government
Subscribe for More Information
September 18, 2014
16:00 EDTBPOptions Update; September 18, 2014
Subscribe for More Information
05:33 EDTCBSTCubist opens international headquarters in Zurich, will invest $400M in R&D
Subscribe for More Information
September 17, 2014
14:57 EDTGSKProsensa announces commencement of re-dosing of drisapersen
Subscribe for More Information
11:01 EDTTEVAActavis drops after NY AG seeks to block Alzheimer drug switch
Subscribe for More Information
08:05 EDTTEVAEagle Pharm says Teva requests motion to dismiss Bendamustine lawsuit
Subscribe for More Information
07:40 EDTBPUBS to hold a conference
Houston Energy Bus-less Tour is being held in Houston on September 17-19 with webcasted company presentations to begin on September 17 at 8:30 am; not all company presentations may be webcasted. Webcast Link
07:39 EDTGSK, BPMorningstar to hold a conference
Management Behind the Moat Conference to be held in Chicago on September 17-18.
September 16, 2014
16:00 EDTBPOptions Update; September 16, 2014
Subscribe for More Information
11:51 EDTJAZZOECD looks to close tax loopholes with new proposals
Subscribe for More Information
11:26 EDTBPBP to reduce personnel in Alaska operations after stake sales, Reuters says
Subscribe for More Information
10:47 EDTBPBadri sees OPEC lowering oil output target at next meeting, Reuters says
Subscribe for More Information
07:33 EDTGSKMylan initiates Phase III clinical trials for Advair Diskus and Lantus
Mylan (MYL) announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's (GKS) Advair Diskus and its insulin analog to Sanofi's (SNY) Lantus. In October Mylan will commence a Phase III clinical trial to evaluate the equivalence of its product to Advair Diskus when administered by inhalation in adult asthma patients.
07:31 EDTNVS, GSKEuropean Association for Study of Diabetes to hold annual meeting
50th Annual Meeting of EASD to be held in Vienna, Austria on September 15-19.
05:46 EDTBPStocks with implied volatility movement; BP PG
Stocks with implied volatility movement; BP (BP) 18, Procter & Gamble (PG) 12 according to iVolatility.
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use